Pharmaceutical pricing in Japan: market evidence for rheumatoid arthritis treatment.

Although the existing pricing rules in Japan are very comprehensive they do not necessarily capture differences in product characteristics. The findings here support the notion that competitive forces are weak in highly regulated markets such as Japan.